ClinicalTrials.gg
Enrolling by invitationNCT06973018eRehabCogUpdated May 15, 2025

Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments

An interventional study of eRehabCog and CogMed QM in Traumatic Brain Injury, Stroke and Multiple Sclerosis, sponsored by Aniko Bartfai. Enrolling by invitation at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-15.

Sponsored by Aniko Bartfai · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as enrolling by invitation.
  • Registered 4 years after the study started (first participant enrolled May 2021, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Acquired brain injury and neurological disorders cause cognitive deficits, which in turn cause reduced participation in everyday life. Cognitive rehabilitation, where patients learn about cognition, cognitive deficits and ways to circumvent problems arising from deficits can increase participation and quality of life. ERehabCog is an internet delivered cognitive rehabilitation program intended for patients suffering mild to moderate impairments. The program consists of information and homework assignments, which take approximately 10 weeks to complete with the assistance of a therapist. Effects are evaluated through measures of everyday life participation, mood, and life satisfaction and compared with an attention training program. This study aims to contribute to the evidence base for internet delivered cognitive rehabilitation for mild to moderate cognitive impairments. Evidence based interventions are vital to use the potential of technology to the benefit of affected patients.

Read the detailed description

When broadly defined, diseases and injuries affecting the central nervous system are one of the leading causes of disease burden in the world affecting more than 3 billion people. With such a large proportion of the global population affected, optimization of limited resources in the form of specialized rehabilitation is instrumental to ensuring sustainable public health.

The consequences of acquired brain injuries (ABIs) and neurological disorders are multifaceted, causing diminished functional capacity in a range of areas. Cognitive impairments are common, affecting ability to work, take on reponsibilities at home and in the community. Relationships in all significant life areas can be disrupted. As a result, patients may experience a significant shift in a plurality of life roles. Rehabilitation aims to help patients recapture premorbid capacities and reduce the impact of deficits while considering the needs and context of the patient. Cognitive rehabilitation has the potential to ameliorate patient outcomes. Patients in Sweden are offered cognitive rehabilitation as a part of multimodal rehabilitation programs, typically provided in university hospital settings. The demand for such interventions is greater than the amount provided. Patients with mild cognitive deficits are generally less prioritized than those with greater impairments. Internet provided rehabilitation programs can increase the accessibility of cognitive rehabilitation.

eRehabCog is an internet-delivered 10 module cognitive rehabilitation program designed to aid patients experiencing mild to moderate cognitive deficits following acquired brain injury or neurological disorders. The philosophy behind the development of eRehabCog is grounded in a compensatory-metacognitive approach. That is to say, patients learn about cognitive functions, consequences of deficits and ways to compensate. This approach has both a practical component where patients learn strategies they may use in their everyday life and a self-reflective component where patients learn to think about their thinking in such a way to raise their awareness of their functioning.

CogMed QM is a 10 week digital working memory training program which has been evaluated in children with ADHD and adults with stroke, showing improvements in working memory function. CogMed QM is a restitutive training program, intended to help patients retake diminished working memory capacity.

The overall aim of this study is to evaluate the efficacy of eRehabCog for patients experiencing mild to moderate cognitive deficits. Specific aims are to 1) evaluate the efficacy of eRehabCog for patients with ABI and ND admitted to community neurorehabilitation 2) compare the effects of eRehabCog to CogMed QM

The study will recruit 64 patients enrolled in community neurorehabilitation. Patients recruited will be ≥ 18 years old, have obtained a score ≥ 21 on Montreal Cognitive Assessment (MoCA), living in their home, with our without assistance and with access to computer and/or functionally ecquivalent device. Exclusion criteria will be progressive neurocognitive impairment (i.e dementia), substance abuse, insufficient Swedish language capabilities, insufficiently stable living situation to commit to a 10 week long program. Community neurorehabilitation teams participating in the study will be randomized to either eRehabCog or CogMed QM.

The primary outcome measure is the Mayo Portland Adaptability Inventory - Fourth edition (MPAI-4) Participation.

Secondary outcome measures are MPAI-4 Total score, ability and adjustment, Hospital Anxiety and Depression Scale (HADS), Life Satisfaction Scale - 11 items (LiSat-11), Community Integration Questionnaire - revised (CIQ-R) and Patient Satisfaction Questionnaire (PSQ).

Background information on patients general status including socioeconomic factors and medical factors such as time since diagnosis is also collected. Behavioural measures such as time in the program, amount of messages to therapist and number of logins are additionally collected throughout participation.

02

Conditions studied

  • Traumatic Brain Injury
  • Stroke
  • Multiple Sclerosis
  • Parkinsons Disease (PD)
  • Post-COVID-19 Condition

Keywords

  • brain injury
  • cognitive rehabilitation
  • nervous system disorders
  • eHealth
  • self assessment
03

In context

Brain Injuries, Traumatic

1,818 studies on the registry are indexed under Brain Injuries, Traumatic; 460 are open to participants now.

This study's planned enrollment of 64 is above the median of 55 across 1,158 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

This is the only study on the registry with Aniko Bartfai as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Enrolled in community neurorehabilitation in Stockholm, Sweden
  • Mild to moderate cognitive impairment as a consequence of acquired brain injury or nervous system disease
  • MoCA 21 ≥
  • Sufficient command of Swedish language
  • Access to internet connected device and internet connection

Exclusion criteria

Exclusion Criteria:

  • Severe and enduring psychiatric or behavioural disorders (i.e Schizophrenia, substance abuse)
  • Suspected or diagnosed dementia
  • Homelessness or other social instability rendering access to internet unpredictable
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    eRehabCog

    10 week (1 hour / week, 10 hours in total) internet delivered manualised cognitive rehabilitation

    Behavioral: eRehabCog

  • Active comparator
    CogMed QM

    5 week (2 hours / week, 10 hours in total) internet delivered working memory training program

    Behavioral: CogMed QM

Interventions

  • BehavioraleRehabCog

    eRehabCog is a manualised internet delivered compensatory cognitive rehabilitation program (10 weeks, 1 hour per week, 10 hours in total). It is designed to improve patient self efficacy and participation in everyday life activities through compensatory strategy learning

  • BehavioralCogMed QM

    CogMed QM is an internet delivered training program (5 weeks, 2 hours per week, 10 hours in total) designed to improve patients working memory

06

What researchers measure

Primary outcomes

  1. Mayo Portland Adaptability Inventory - fourth edition (MPAI-4), Participation subscale

    Change in T-score

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

Secondary outcomes

  1. MPAI-4 Adaptability subscale

    Change in T-score

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

  2. MPAI-4 Abilities subscale

    Change in T-score

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

  3. MPAI-4 Total score

    Change in T-score

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

  4. Hospital Anxiety and Depression Scale

    Change in average total score

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

  5. Life Satisfaction Questionnaire (LiSat-11)

    Change in average total score

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

  6. Community Integration Questionnaire - Revised (CIQ-R)

    Change in total and subscale scores

    Time frame: Two weeks before intervention, at intervention start, at the end of treatment at 10 weeks, at six months post intervention ed

Other outcomes

  1. Patient satisfaction questionnaire

    Correlation to primary and secondary outcome measures

    Time frame: End of treatment at 10 weeks

  2. Montreal Cognitive Assessment (MoCA)

    Correlation to primary and secondary outcome measures

    Time frame: Baseline

07

Study locations

1 site
  • Danderyd Hospital
    Stockholm, Stockholm County 116 88, Sweden
08

References and documents

Individual participant data

Plan to share: No — According to the decision of the ethical review board, IPD can not be shared.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2021 (actual). Primary completion is estimated for Jul 2025, 49 months after the start.

Of 491 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 64. This study's planned 49 months is above that.

Counting every sponsor, half of 515 studies reached it within 36 months; a quarter within 21 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2025
First posted
May 15, 2025
StartActual
May 2, 2021
Primary completionEst.
Jul 1, 2025
CompletionEst.
Dec 31, 2027
Last update
May 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06973018
Lead sponsor
Aniko Bartfai
Collaborators
Region Stockholm
Responsible party
Aniko Bartfai (senior professor in neuropsychology, Karolinska Institutet, Danderyd Hospital) — Sponsor-investigator
First posted
May 15, 2025
Start date
May 2, 2021
Primary completion
Jul 1, 2025 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
May 15, 2025

Study contacts

Aniko Bartfai, PhD
principal investigator · Karolinska Institutet Danderyds Sjukhus (KIDS), Department of medical rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion